Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @
  • AstraZeneca
  • BAE Systems
  • Barclays
  • BP
  • Britain
  • British American Tobacco
  • Compass Group
  • Diageo
  • Glencore
  • GSK
  • HSBC
  • Lloyds Banking Group
  • London
  • London Stock Exchange Group
  • National Grid
  • NatWest
  • Reckitt Benckiser
  • Rio Tinto
  • Rolls-Royce
  • Shell
  • Standard Chartered
  • UK
  • Unilever
Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @

Browsing Tag

NCCN

1 post
AAstraZeneca
AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer
Read More

AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

  • September 1, 2026
WILMINGTON, Del., September 01, 2026–(BUSINESS WIRE)–AstraZeneca today announced the successful completion of the previously announced exclusive license agreement…
Britain | EUROPESAYS.COM
www.europesays.com